• Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)

  • Mar 18 2025
  • Duración: 18 m
  • Podcast

Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS.

    Related Content:

    • Sevoflurane Sedation in Acute Respiratory Distress Syndrome
    • Inhaled Sedation in Acute Respiratory Distress Syndrome
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles